↓ Skip to main content

The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

Overview of attention for article published in Annals of the Rheumatic Diseases, February 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
25 news outlets
blogs
3 blogs
policy
3 policy sources
twitter
14 X users
patent
1 patent

Citations

dimensions_citation
844 Dimensions

Readers on

mendeley
886 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
Published in
Annals of the Rheumatic Diseases, February 2014
DOI 10.1136/annrheumdis-2013-204627
Pubmed ID
Authors

Marita Cross, Emma Smith, Damian Hoy, Loreto Carmona, Frederick Wolfe, Theo Vos, Benjamin Williams, Sherine Gabriel, Marissa Lassere, Nicole Johns, Rachelle Buchbinder, Anthony Woolf, Lyn March

Abstract

To estimate the global burden of rheumatoid arthritis (RA), as part of the Global Burden of Disease 2010 study of 291 conditions and how the burden of RA compares with other conditions.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 886 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Colombia 1 <1%
Kazakhstan 1 <1%
United Kingdom 1 <1%
Brazil 1 <1%
Russia 1 <1%
Canada 1 <1%
Unknown 878 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 122 14%
Researcher 103 12%
Student > Ph. D. Student 101 11%
Student > Master 95 11%
Student > Postgraduate 54 6%
Other 141 16%
Unknown 270 30%
Readers by discipline Count As %
Medicine and Dentistry 255 29%
Biochemistry, Genetics and Molecular Biology 56 6%
Nursing and Health Professions 47 5%
Pharmacology, Toxicology and Pharmaceutical Science 47 5%
Agricultural and Biological Sciences 38 4%
Other 134 15%
Unknown 309 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 221. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2022.
All research outputs
#172,383
of 25,292,646 outputs
Outputs from Annals of the Rheumatic Diseases
#66
of 7,769 outputs
Outputs of similar age
#1,382
of 231,639 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#3
of 200 outputs
Altmetric has tracked 25,292,646 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,769 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 231,639 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 200 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.